Year |
Citation |
Score |
2019 |
Curry JM, Besmer DM, Erick TK, Steuerwald N, Das Roy L, Grover P, Rao S, Nath S, Ferrier JW, Reid RW, Mukherjee P. Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice. Plos One. 14: e0224309. PMID 31693710 DOI: 10.1371/Journal.Pone.0224309 |
0.787 |
|
2014 |
Roy LD, Sahraei M, Schettini JL, Gruber HE, Besmer DM, Mukherjee P. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches. Bmc Cancer. 14: 225. PMID 24674692 DOI: 10.1186/1471-2407-14-225 |
0.615 |
|
2014 |
Kidiyoor A, Schettini J, Besmer DM, Rego SL, Nath S, Curry JM, Roy LD, Dréau D, Mukherjee P. Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population. Frontiers in Immunology. 5: 67. PMID 24605110 DOI: 10.3389/Fimmu.2014.00067 |
0.788 |
|
2013 |
Hastie E, Besmer DM, Shah NR, Murphy AM, Moerdyk-Schauwecker M, Molestina C, Roy LD, Curry JM, Mukherjee P, Grdzelishvili VZ. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma. Journal of Virology. 87: 10283-94. PMID 23864625 DOI: 10.1128/Jvi.01412-13 |
0.675 |
|
2013 |
Das Roy L, Curry JM, Sahraei M, Besmer DM, Kidiyoor A, Gruber HE, Mukherjee P. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling. Breast Cancer Research : Bcr. 15: R32. PMID 23577751 DOI: 10.1186/Bcr3412 |
0.687 |
|
2013 |
Curry JM, Thompson KJ, Rao SG, Besmer DM, Murphy AM, Grdzelishvili VZ, Ahrens WA, McKillop IH, Sindram D, Iannitti DA, Martinie JB, Mukherjee P. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Journal of Surgical Oncology. 107: 713-22. PMID 23335066 DOI: 10.1002/Jso.23316 |
0.691 |
|
2013 |
Curry JM, Besmer DM, Roy LD, Grover P, Nath S, Rao S, Mukherjee P. Abstract 475: Combinational treatment with MUC1 vaccine and Indomethacin reduces breast tumor burden via a COX-independent pathway. Cancer Research. 73: 475-475. DOI: 10.1158/1538-7445.Am2013-475 |
0.766 |
|
2012 |
Schettini J, Kidiyoor A, Besmer DM, Tinder TL, Roy LD, Lustgarten J, Gendler SJ, Mukherjee P. Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity. Cancer Immunology, Immunotherapy : Cii. 61: 2055-65. PMID 22543528 DOI: 10.1007/S00262-012-1264-Y |
0.712 |
|
2012 |
Sahraei M, Roy LD, Curry JM, Teresa TL, Nath S, Besmer D, Kidiyoor A, Dalia R, Gendler SJ, Mukherjee P. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene. 31: 4935-45. PMID 22266848 DOI: 10.1038/Onc.2011.651 |
0.783 |
|
2012 |
Murphy AM, Besmer DM, Moerdyk-Schauwecker M, Moestl N, Ornelles DA, Mukherjee P, Grdzelishvili VZ. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma. Journal of Virology. 86: 3073-87. PMID 22238308 DOI: 10.1128/Jvi.05640-11 |
0.647 |
|
2012 |
Besmer D, Kidiyoor A, Nath S, Roy LD, Curry J, Mukherjee P. Abstract 5400: Investigating the role of IDO in MUC1 expressing breast cancers Cancer Research. 72: 5400-5400. DOI: 10.1158/1538-7445.Am2012-5400 |
0.807 |
|
2012 |
Murphy A, Besmer D, Moerdyk-Schauwecker M, Moestl N, Ornelles D, Mukherjee P, Grdzelishvili V. Abstract 2714: Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma Cancer Research. 72: 2714-2714. DOI: 10.1158/1538-7445.Am2012-2714 |
0.717 |
|
2012 |
Roy LD, Curry JM, Sahraei M, Kidiyoor A, Besmer DM, Gruber HE, Mukherjee P. Abstract 1389: Arthritis augments breast cancer metastasis: Role of mast cells and SCF/c-Kit signaling Cancer Research. 72: 1389-1389. DOI: 10.1158/1538-7445.Am2012-1389 |
0.741 |
|
2011 |
Besmer DM, Curry JM, Roy LD, Tinder TL, Sahraei M, Schettini J, Hwang SI, Lee YY, Gendler SJ, Mukherjee P. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Cancer Research. 71: 4432-42. PMID 21558393 DOI: 10.1158/0008-5472.Can-10-4439 |
0.761 |
|
2011 |
Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene. 30: 1449-59. PMID 21102519 DOI: 10.1038/Onc.2010.526 |
0.767 |
|
2011 |
Kidiyoor A, Schettini J, Roy LD, Besmer D, Tinder T, Mukherjee P. Abstract 3644: Pancreatic tumor cells that develop within Muc1 knock-out mice generate less immunosuppressive MDSCs in vitro Cancer Research. 71: 3644-3644. DOI: 10.1158/1538-7445.Am2011-3644 |
0.758 |
|
2011 |
Besmer D, Roy LD, Curry J, Tinder T, Manouchehrabadi M, Schettini J, Hwang S, Lee Y, Gendler S, Mukherjee P. Abstract 1070: Pancreatic Ductal Adenocarcinoma (PDA) mice lacking Mucin 1 has a profound defect in tumor growth and metastasis Cancer Research. 71: 1070-1070. DOI: 10.1158/1538-7445.Am2011-1070 |
0.776 |
|
Show low-probability matches. |